Lincoln Pharmaceuticals Limited (NSE:LINCOLN)

Lincoln Pharmaceuticals Revenue

Lincoln Pharmaceuticals had revenue of 1.91B INR in the quarter ending September 30, 2026, with 17.13% growth. This brings the company's total for the last twelve months to 7.22B, up 14.25% year-over-year. In the fiscal year ending March 31, 2026, Lincoln Pharmaceuticals had annual revenue of 6.71B with 7.67% growth.

• Revenue (ttm): 7.22B
• Revenue Growth: +14.25%
• P/S Ratio: 1.45
• Revenue / Employee: 5.34M
• Employees: 1,352
• Market Cap: 10.45B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• Rest of World 3.93B 58.5%
• India 2.78B 41.5%

Fiscal year ended Mar 31, 2026 See the full Lincoln Pharmaceuticals breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	6.71B	478.00M	7.67%
Mar 31, 2025	6.23B	426.81M	7.35%
Mar 31, 2024	5.81B	702.41M	13.76%
Mar 31, 2023	5.10B	381.86M	8.09%
Mar 31, 2022	4.72B	479.38M	11.30%

Data Source: S&P Global Market Intelligence Last updated: Oct 29, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 9, 2026

Data Sources Report a data error